RT @professorzinnel: $nvax to present updated phase III #RSV data! Buyout soon?
$jnj $pfe $gsk $mrk $nvax $jagx $atos $nviv $dpw $zsan $bp…
$nvax to present updated phase III #RSV data! Buyout soon?
$jnj $pfe $gsk $mrk $nvax $jagx $atos $nviv $dpw $zsan… https://t.co/z0Kygma44W
$PFE Pfizer, Inc. SEC Filing: Form 4 https://t.co/KsZa6o1Siy
#Salesforce Selective Enrichening Leads To DEBT! $amzn $agn $brk $crm $cmg $dis $f $fred $googl $gild $hlf $iep… https://t.co/6oaJHEyeQ0
@buysidebio Wait until the IPO??? Exactly what does that have to do with the ATTR drug war? If they have a viable h… https://t.co/yhVbxiy2Wo
Marshwinds Advisory Co. Has $4.47 Million Stake in Pfizer Inc. (NYSE:PFE) https://t.co/aJLezsDJwB $PFE #stocks #stockmarket
What's My NEXT? I'd Like a Wife Some Day! I Can't Afford One Right Now Though! $amzn $brk $crm $cmg $dis $f $fred… https://t.co/m8IiHIWtMb
@buysidebio But is the real threat to $IONS AND $ALNY the data or $PFE vast commercial structure and experience launching drugs?
@tradernico Alnylam is a science-based, data-driven company, but competing head-to-head with $PFE in ATTR amyloidos… https://t.co/mHIrPfofxR
$AMZN Lost $37.1B Today After Deutsche Bank Note & More Mr @Potus @realDonaldTrump Tweets $amzn $brk $crm $cmg… https://t.co/x5BC5bf4VT
CheckThis Out! Looking to do a show! We Are The New Media & Bringing It To the People $aapl $amzn $brk $crm $cmg… https://t.co/JjAl31DTrS
Maybe Ignore Duetshe Bank Next Time? $aapl $amzn $brk $crm $cmg $dis $f $fred $googl $gild $hlf $iep $ibm $jnj $ko… https://t.co/ot6TzIi5by
RT @ChrisLacoursier: #biotech $NWBO about to take ALL market share $NVCR #CellTherapy #DCVAX P3 trial data pending MOS possibly double SOC…
RT @RNAiAnalyst: Pfizer Study Clears Way for Broad Cardiomyopathy Label of TTR-lowering Drugs (blog): https://t.co/ynl9OUr2Fn $IONS $AKCA $…
RT @ChrisLacoursier: #biotech $NWBO about to take ALL market share $NVCR #CellTherapy #DCVAX P3 trial data pending MOS possibly double SOC…
@tradernico $ALNY and $IONS have both presented their data, and ALNY has already submitted its NDA to the FDA; in c… https://t.co/vDMdzIy62X
$PFE Pfizer, Inc. SEC Filing: Form 4 https://t.co/eKsKlJkxSU
#estate #asset watch: price / vol. leaders today: $AMZN $AAPL $FB $NVDA $MSFT $TSLA $NFLX $GOOGL $INTC $MU $BABA… https://t.co/gXXmg1e4mV
There's A Lot of Meat Still Left on This Bone! They're Taking on Debt &Paid Too Much $amzn $agn $brk $crm $cmg $dis… https://t.co/1iJcaABQio
@tradernico That, I agree $ALNY has a strong, diversified pipeline with great science, but in the near-term they ha… https://t.co/VdN1ku88Fv
$PFE:
New Insider Filing on
Director
JAMES M KILTS:
https://t.co/s4MzTtlH35
$PFE ALERT: New Pfizer SEC Filing
From our Stock News Alerts App
RT @WarrenBuffetHQ: The proper response to conflict, whether it lies within or without us, is disengagement
The Best Stock Investment For…
Pfizer $PFE Getting Somewhat Positive Press Coverage, Analysis Finds https://t.co/HpcptUAXmX
$PFE Max Pain=35.50. Maturity=04/06/2018. #maxpain #options https://t.co/P8rDM3uiYG https://t.co/SK1zx0kyd9
RT @ChrisLacoursier: #biotech $NWBO about to take ALL market share $NVCR #CellTherapy #DCVAX P3 trial data pending MOS possibly double SOC…
Dow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ https://t.co/tE01Lw1rzM #stockmarket #stocks #trading #DowJones
$NVCN Earnings Growth Better Than The Industrys
https://t.co/p5fJZSMaO6 $AAPL $GOOG $INTC $AMZN $MSFT $CMCSA $PFE… https://t.co/P4hBWTv3f6
Short setups $MRK $AXTA $COST $PFE $KMX $QSR $PWR $ROST $CC https://t.co/NtCLfGyMi7
$NVCN new target today mid the doom & gloom is $1.88! Shhh. $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU… https://t.co/1T2NjaNVJj
RT @aaaamhim: $NVCN new target today mid the doom & gloom is $1.88! Shhh. $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $X…
RT @aaaamhim: $NVCN Earnings Growth Better Than The Industrys
https://t.co/p5fJZSMaO6 $AAPL $GOOG $INTC $AMZN $MSFT $CMCSA $PFE $NFLX $NOK…
$NVCN BOSTON SCIENTIFIC MAY BUY THEM OUT! https://t.co/6zSvy70bE4 $AAPL $GOOG $INTC $AMZN $MSFT $CMCSA $PFE $MU… https://t.co/l3YTsCantm
Dow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ https://t.co/DKVRp58o9M #stockmarket #stocks #trading #DowJones
RT @aaaamhim: $NVCN BOSTON SCIENTIFIC MAY BUY THEM OUT! https://t.co/6zSvy70bE4 $AAPL $GOOG $INTC $AMZN $MSFT $CMCSA $PFE $MU $NFLX $NOK $…
Brokerages Set Pfizer $PFE PT at $39.42 https://t.co/dSY5Ds15R8
RT @FDAadcomm: April and May #FDAadcomm Meetings
$GWPH $LLY $PFE $AKAO $MNK $AKCA $INSY https://t.co/QcdUI1MW6n
RT @Rags_vs_Riches: ***** #NATESTO ABOUT TO WIN $3.8 BILLION MARKET *****
$AYTU Bioscience
#NASDAQ
59 cents
52 week high = $18 +
$JNJ $SY…
RT @OneOClockDrop: HUGE VOLUME AND GAINS FOR $DIRV BEFORE NEWS. STILL UNDERVALUED $msft $amzn $fb $goog $jnj $jpm $googl $bac $wfc $wmt $cv…
RT @chartseer: Short setups $MRK $AXTA $COST $PFE $KMX $QSR $PWR $ROST $CC https://t.co/NtCLfGyMi7
$FLCR in b4 the crowd 2000%+ potential $trx $btc $ltc $nvcn $xrp $dash $ada $trx $nxt $eth $usdt $qtum $xem $xlm… https://t.co/TnVTn0qgl7
RT @WarrenBuffetHQ: Switch your mindset from problems to solutions. See blessings instead of lack. When you change how you look at things,…
Price Moves vs Expected Moves $PFE $TEVA $CVS $BMY $MRK $CELG $AMGN $JNJ $GILD $ABBV $AGN $VRX https://t.co/T6y5z4l70A
FLCR Fact INSIDERS OWN 40% $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA… https://t.co/Pw848qrxsS
$FLCR unlike 99% of OTC HAS A REAL PRODUCT OWNS A MOVIE THEATER $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE… https://t.co/yShNuD1sBu
RT @bosbizmax: $ALNY market cap decline now stands at *$3 BILLION* since $PFE announced positive trial results on Thursday afternoon for a…
Centers for Medicare & Medicaid Services to allow insurers to include low-cost generic drugs in their approved list… https://t.co/X8Yce3w2b3
RT @WarrenBuffetHQ: If you want to be successful, it's just this simple. Know what you are doing. Love what you are doing. And believe in w…
Short sell volume percent for $TXMD at 2018-04-02 is 71%. https://t.co/RPoQf2jv5A $PFE 73% $LCI 77% $ABBV 43%
Pfizer $PFE Shares Bought by Country Trust Bank https://t.co/Cw5GBBylYB
RT @ChrisLacoursier: #biotech $NWBO about to take ALL market share $NVCR #CellTherapy #DCVAX P3 trial data pending MOS possibly double SOC…
RT @tgtxdough: BMO U.S. IO Market $MRK $BMY $AZN $PFE and $ROG): Rolling twelve-month IMS reported sales for Immuno-Oncology drugs in U.S.…
RT @Drugdoctor2014: Is your POT STOCK RED HOT? Maybe you have wrong ones? $EMHTF $NDEV $AMFE $CNNRF $AERO $MRPHF $CBICF $TBPMF $HYYDF $ACOL…
RT @fezziwig2008: $HALO's new $PFE PegpH20 collaboration is being met with irrational selling. 2 major catalysts will unwind all of this in…
RT @ChrisLacoursier: #biotech $NWBO about to take ALL market share $NVCR #CellTherapy #DCVAX P3 trial data pending MOS possibly double SOC…
RT @StockScoops: Marshwinds Advisory Co. Has $4.47 Million Stake in Pfizer Inc. (NYSE:PFE) https://t.co/aJLezsDJwB $PFE #stocks #stockmarket
Arthur M. Cohen & Associates LLC Purchases Shares of 8,343 Pfizer $PFE https://t.co/VxqXJPaGxH
Pfizer $PFE Shares Bought by Schaper Benz & Wise Investment Counsel Inc. WI https://t.co/DbNkSrIzx6
Pfizer $PFE Shares Bought by Security Asset Management https://t.co/ZvfhrheRU9
Schaper Benz & Wise Investment Counsel Inc. WI Purchases 2,000 Shares of Pfizer $PFE https://t.co/nf5ltYlLWf
Farmers & Merchants Investments Inc. Boosts Stake in Pfizer $PFE https://t.co/SJQrlUlDc5
@Mahmissa $PFE could write a check for a $billion out of their petty cash.
#SecAzar appoints former $PFE director and $CVS Caremark VP Daniel Best as #DrugPricing advisor to lead effort in l… https://t.co/W3NvUm3UU7
RT @WarrenBuffetHQ: Sometime you have to unfollow people in real life
The Best Stock Investment For 2018
https://t.co/7jGxMoJqTc
$SPY $AA…
Farmers & Merchants Investments Inc. Boosts Stake in Pfizer $PFE https://t.co/yvGYucQm4O
#estate asset watch: price / vol. leaders Monday: $AMZN $AAPL $FB $NVDA $MSFT $TSLA $NFLX $GOOGL $INTC $MU $BABA… https://t.co/UIwRtVQkwq
$WMT $AMZN $AAPL $COST $INTC $QCOM $MSFT $GM $X $PFE $TSN https://t.co/yH1WJU6KKi
Pfizer $PFE Given a $43.00 Price Target by BMO Capital Markets Analysts https://t.co/EIsVZohtXg
RT @bio_clouseau: $PFE seems to be stepping away from CART unlike $CELG $GILD
$PFE seems to be stepping away from CART unlike $CELG $GILD
RT @BehaviorFin: $CLLS $PFE $KITE $JUNO $CELG $GILD
Allogene intends to assume from Pfizer the global strategic collaboration agreement ori…
This $CLLS $PFE Allogene news begs the questions, why didn't $GILD keep @Arie_Belldegrun and the Kite team around… https://t.co/WYjEb3i2As
In exchange, Pfizer is getting a 25% stake in Allogene,. $CLLS $PFE $KITE $JUNO $CELG $GILD https://t.co/CQXkeA32uI
$CLLS $PFE $KITE $JUNO $CELG $GILD
Allogene intends to assume from Pfizer the global strategic collaboration agreem… https://t.co/TeqstjEFQ7
Wowee $CLLS $PFE $KITE $GILD #CART https://t.co/nRNJncM9cn
RT @adamfeuerstein: @RebeccaDRobbins David Chang quit $GILD in March to hook up again with Arie B. $PFE stepping back from the CAR-T game.
@RebeccaDRobbins David Chang quit $GILD in March to hook up again with Arie B. $PFE stepping back from the CAR-T game.
Yesterdays Large Market-On-Close Stock OrderImbalances $T $BRK.B $UTX $PFE $JNJ $JPM $BAC $OXY $C $XOM $WFC $DAL… https://t.co/GKjN14HOk5
RT @BoerseGer: $PFE $CLLS Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate…
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
RT @datamonitor_JA: Dr. Arie Belldegrun @Arie_Belldegrun + Dr. David Chang (formerly of $KITE) will be essentially taking over leadership o…
Pfizer to contribute assets backing CAR T developer Allogene Therapeutics https://t.co/zzbDCKEK8S #premarket $PFE
Pfizer to contribute assets backing CAR T developer Allogene Therapeutics https://t.co/cfnHoilRN3 #premarket $PFE
“I looked at the data and said ‘David, we need to do this, it’s a gold mine.’ It’s a deal I couldn’t refuse,” says… https://t.co/J0QRWv3bc5
RT @datamonitor_JA: This $CLLS $PFE Allogene news begs the questions, why didn't $GILD keep @Arie_Belldegrun and the Kite team around
Thin…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
RT @fwpharma: Pfizer hands over allogeneic CAR T-cell therapy portfolio to Allogene https://t.co/avjGsx8jnA $PFE
Something tells me @Arie_Belldegrun likely views UCART19 $CLLS
as a "destination therapy" rather than the bridge to… https://t.co/xnEs59XGjM
Pfizer hands over allogeneic CAR T-cell therapy portfolio to Allogene https://t.co/avjGsx8jnA $PFE
RT @matthewherper: Arie and David are licensing Cellectis' off-the-shelf CART from $PFE. And boy are they excited.
Also, they raised $300…
Dr. Arie Belldegrun @Arie_Belldegrun + Dr. David Chang (formerly of $KITE) will be essentially taking over leadersh… https://t.co/GlzO5PRzEK
At #JefferiesCellTherapy where $CLLS CEO has announced the #Allogene deal. $PFE maintains a financial stake. Alloge… https://t.co/2kAFcgdgTC
RT @matthewherper: Arie and David are licensing Cellectis' off-the-shelf CART from $PFE. And boy are they excited.
Also, they raised $300…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
@bio_clouseau Maybe $PFE will buyout $ZIOP (2 days point of care)?
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @BoerseGer: $PFE $CLLS Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate…
RT @matthewherper: Arie and David are licensing Cellectis' off-the-shelf CART from $PFE. And boy are they excited.
Also, they raised $300…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
Very interesting deal here. $ADAP has similar deal to develop off-the-shelf TCR therapies with Universal Cells. Wo… https://t.co/AcMpBBXzZt
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
RT @matthewherper: Arie and David are licensing Cellectis' off-the-shelf CART from $PFE. And boy are they excited.
Also, they raised $300…
Nelson Roberts Investment Advisors LLC Raises Position in Pfizer $PFE https://t.co/l4Pnd3T4o7
RT @biotech_junkie: @TheSkeptic21 @Jdalexander64 @_B_I_O_T_E_C_H_ @antonioregalado @mchilberg @matthewherper @PrezCamacho rumor is $PFE to…
RT @_B_I_O_T_E_C_H_: @SilenceCEO @bradloncar still thinkin $PFE will "dump" $CLLS in june
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
$PFE $CLLS Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to A… https://t.co/OFdB0kjVdl
$PFE https://t.co/KcLWLrq8B7
$PFE:
Pfizer and Allogene Therapeutics Enter into Asset Contribution …:
https://t.co/GHKUO6wgKo
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
Arie and David are licensing Cellectis' off-the-shelf CART from $PFE. And boy are they excited.
Also, they raised… https://t.co/frQZHjTKXW
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
$PFE $CLLS Dr. André Choulika, Cellectis CEO on the deal https://t.co/0VvrK1N5UB
$PFE Pfizer and Allogene Therapeutics entered into an asset contribution agreement for Pfizer’s portfolio of ass… https://t.co/xe9NZqlDPC
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
RT @JacobPlieth: $PFE to $CLLS just now https://t.co/Y2VrU82zrh
Arie Belldegrun raises $300M, grabs Pfizer’s $PFE allogeneic CAR-T portfolio and launches a groundbreaking drive to… https://t.co/fFhPni9icv
RT @adamfeuerstein: Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets, inc…
$PFE to $CLLS just now https://t.co/Y2VrU82zrh
Act 2 for Kite execs Arie B., David Chang: A new off-the-shelf CAR-T startup seeded with $PFE Servier $CLLS assets,… https://t.co/CyBMERuDmc
$PFE Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-… https://t.co/oNahDmqdq4
RT @JohnCendpts: Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commerciali…
Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to comm… https://t.co/6ii7XRqRXG
$CPRX $MNOV $PFE https://t.co/EEJcQ5iFsZ
$PFE #Pfizer Inc. Pfizer Inc. - December 2017 (LTM): Peer Snapshot: Compares key performance metrics against indust… https://t.co/QaLwVoNdbY